Weight-loss drug mimicking exercise may help treat obesity, diabetes
HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the.
HQ Team October 2, 2023: Walking more than five flights of stairs a day can cut the risk of heart disease by 20%,.
HQ Team September 29, 2023: Changing heat patterns are intensifying severe cyclones over the Eastern Arabian Sea affecting artisanal fishing livelihoods. Weather systems.
HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.
HQ Team September 29, 2023: Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder.
HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of.
HQ Team September 29, 2023: The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a.
HQ Team September 28, 2023: Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by.
HQ Team September 28, 2023: US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all.
HQ Team September 28, 2023: Swiss biotechnology company, Basilea Pharmaceutica’s last stage trials of ceftobiprole to treat bacterial bloodstream infections have shown favourable.